WuXi Eyes Growing Biologics Business With New Integrated Center
This article was originally published in PharmAsia News
An integrated biologics solution center is China's largest CRO WuXi AppTec's first investment completes its going private move. Aiming to provide full range of services to clients developing antibody drugs, WuXi plans more investment within the next 12 months.
Register for our free email digests: